The Patent Finder

Terms ending in 2030

Bayer Pharma Aktiengesellschaft

Every in-force patent on Bayer Pharma Aktiengesellschaft's record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US D748,244Electronic Autoinjector
In force
 · High confidence
Bayer Pharma Aktiengesellschaft and Olufsen Medicom A/S, CorporationIn forceHigh confidence
US D748,245Electronic Autoinjector
In force
 · High confidence
Bayer Pharma Aktiengesellschaft and Bang & Olufsen Medicom A/S CorporationIn forceHigh confidence
US 8,586,082Solid Orally Administerable Pharmaceutical Dosage Forms with Rapid Active Principle Release
In force
 · High confidence
Bayer Intellectual Property GmbHIn forceHigh confidence
US 9,084,829Anti-Mesothelin Immunoconjugates and Uses Therefor
In force
 · High confidence
Bayer Intellectual Property GmbHIn forceHigh confidence
US 10,155,00417-Hydroxy-17-Pentafluoroethyl-ESTRA-4,9(10)-DIEN-11-ARYL Derivatives, Method of Production Thereof and Use Thereof for the Treatment of Diseases
In force
 · Medium confidence
Bayer Intellectual Property GmbHIn forceMedium confidence
US 11,617,751Pharmaceutical Composition Containing a Tetrahydrofolic Acid
In force
 · Medium confidence
Bayer Intellectual Property GmbHIn forceMedium confidence
US 9,233,176Systems and Method of Delivering Fluids to a Patient of Varying Concentration
In force
 · High confidence
Bayer Intellectual Property GmbHIn forceHigh confidence
US 9,018,414Substituted 3-Phenylpropionic Acids and the Use Thereof
In force
 · Medium confidence
Bayer Intellectual Property GmbHIn forceMedium confidence
US 8,784,775Compounds for Use in Imaging, Diagnosing And/Or Treatment of Diseases of the Central Nervous System or of Tumors
In force
 · High confidence
Life Molecular Imaging LimitedIn forceHigh confidence
US 8,617,597Pharmaceutical Composition Containing a Tetrahydrofolic Acid
In force
 · High confidence
Bayer Intellectual Property GmbHIn forceHigh confidence
10 of 10 patents shown. Soonest term end first, then patent number.
3 of these are in force and held by Bayer Pharma Aktiengesellschaft.
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited